Xinru Mao

Guangdong Provincial Key Laboratory Of Bone And Joint Degeneration Diseases
Guangzhou, 510515, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Author Correction: Damaged brain accelerates bone healing by releasing small extracellular vesicles that target osteoprogenitors.

Author Correction: Damaged brain accelerates bone healing by releasing small extracellular vesicles that target osteoprogenitors.

Journal: Nature communications

Published: July 03, 2025

Exploring differential gene expression and biomarker potential in systemic lupus erythematosus: a retrospective study.

Exploring differential gene expression and biomarker potential in systemic lupus erythematosus: a retrospective study.

Journal: PeerJ

Published: March 19, 2025

DNA damage repair-related methylated genes RRM2 and GAPDH are prognostic biomarkers associated with immunotherapy for lung adenocarcinoma.

DNA damage repair-related methylated genes RRM2 and GAPDH are prognostic biomarkers associated with immunotherapy for lung adenocarcinoma.

Journal: Genetics and molecular biology

Published: July 09, 2024

Clinical translation for targeting DNA damage repair in non-small cell lung cancer: a review.

Clinical translation for targeting DNA damage repair in non-small cell lung cancer: a review.

Journal: Translational lung cancer research

Published: November 14, 2023

Screening for malignant tumor cells in serous effusions with an automatic hematology analyzer using a novel diagnostic algorithm.

Screening for malignant tumor cells in serous effusions with an automatic hematology analyzer using a novel diagnostic algorithm.

Journal: Annals of translational medicine

Published: December 15, 2021

The prognostic value of longitudinal circulating tumor DNA profiling during osimertinib treatment.

The prognostic value of longitudinal circulating tumor DNA profiling during osimertinib treatment.

Journal: Translational lung cancer research

Published: February 11, 2021

A comprehensive pan-cancer study of fibroblast growth factor receptor aberrations in Chinese cancer patients.

A comprehensive pan-cancer study of fibroblast growth factor receptor aberrations in Chinese cancer patients.

Journal: Annals of translational medicine

Published: November 19, 2020

Development and external validation of a novel nomogram for screening Chinese Lynch syndrome: based on a multicenter, population study.

Development and external validation of a novel nomogram for screening Chinese Lynch syndrome: based on a multicenter, population study.

Journal: Therapeutic advances in medical oncology

Published: November 16, 2020

Novel AMBRA1-ALK fusion identified by next-generation sequencing in advanced gallbladder cancer responds to crizotinib: a case report.

Novel AMBRA1-ALK fusion identified by next-generation sequencing in advanced gallbladder cancer responds to crizotinib: a case report.

Journal: Annals of translational medicine

Published: November 04, 2020

Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China.

Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China.

Journal: Cancer immunology, immunotherapy : CII

Published: August 31, 2020

Clinical impact of uncommon epidermal growth factor receptor exon 19 insertion-deletion variants on epidermal growth factor receptor-tyrosine kinase inhibitor efficacy in non-small-cell lung cancer.

Clinical impact of uncommon epidermal growth factor receptor exon 19 insertion-deletion variants on epidermal growth factor receptor-tyrosine kinase inhibitor efficacy in non-small-cell lung cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 20, 2020

Comparison of Next-Generation Sequencing and Ventana Immunohistochemistry in Detecting ALK Rearrangements and Predicting the Efficacy of First-Line Crizotinib in Patients with Advanced Non-Small Cell Lung Cancer.

Comparison of Next-Generation Sequencing and Ventana Immunohistochemistry in Detecting ALK Rearrangements and Predicting the Efficacy of First-Line Crizotinib in Patients with Advanced Non-Small Cell Lung Cancer.

Journal: OncoTargets and therapy

Published: June 11, 2020

Showing 1-12 of 36

Last Updated: 09/26/2026